Invesco Biotechnology & Genome ETF
PBE
PBE
68 hedge funds and large institutions have $54.4M invested in Invesco Biotechnology & Genome ETF in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
40% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 25
Holders
68
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.87M | |
| 2 | +$2.01M | |
| 3 | +$1.78M | |
| 4 |
VF
Virtu Financial
New York
|
+$795K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$651K |
Top Sellers
| 1 | -$2.28M | |
| 2 | -$1.46M | |
| 3 | -$1.08M | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$803K |
| 5 |
SG Americas Securities
New York
|
-$598K |